Piqray and Lantus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Piqray (alpelisib) and Lantus (insulin glargine recombinant). Common drug interactions include blood glucose increased among females.
The phase IV clinical study analyzes what interactions people have when they take Piqray and Lantus. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.
What is Piqray?
Piqray has active ingredients of alpelisib. eHealthMe is studying from 7,290 Piqray users. Check the latest studies of Piqray.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
25 people who take Piqray and Lantus together, and have interactions are studied.
What are the common drug interactions of Piqray and Lantus, by gender? *:
female:
- Blood glucose increased
- Fatigue (feeling of tiredness)
- Dyspnoea (difficult or laboured respiration)
- Fall
- Feeding disorder (when children refuse to eat certain food groups)
- Glycosylated haemoglobin increased
- Lower respiratory tract infection
- Nausea (feeling of having an urge to vomit)
- Pleuritic pain
- Pneumonia
male:
n/a
What are the common drug interactions of Piqray and Lantus, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Blood glucose increased
- Dehydration (dryness resulting from the removal of water)
- Eating disorder
- Diabetic hyperglycaemic coma (diabetic coma occurs when blood sugar gets too high and the body becomes severely dehydrated)
60+:
- Blood glucose increased
- Fatigue (feeling of tiredness)
- Fall
- Feeding disorder (when children refuse to eat certain food groups)
- Glycosylated haemoglobin increased
- Lower respiratory tract infection
- Nausea (feeling of having an urge to vomit)
- Pleuritic pain
- Pneumonia
- Pyrexia (fever)
What are the existing conditions these people have? *
- Breast Cancer: 9 people, 36.00%
- Breast Cancer Female: 8 people, 32.00%
- Stress And Anxiety: 2 people, 8.00%
- Breast Cancer Metastatic: 2 people, 8.00%
* Approximation only. Some reports may have incomplete information.
Do you take Piqray and Lantus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Piqray and Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Piqray:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Piqray and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on alpelisib and insulin glargine recombinant (the active ingredients of Piqray and Lantus, respectively), and Piqray and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metoclopramide cause Anuria? - 3 seconds ago
- Could Ezetimibe cause Caecitis? - 9 seconds ago
- Drug interactions of Oxycontin and Rezulin - 10 seconds ago
- Zometa and Mitral Valve Prolapse for Women aged 40-49 - 10 seconds ago
- Zometa and Mvp for Women aged 40-49 - 10 seconds ago
- Zometa and Systolic Click-Murmur Syndrome for Women aged 40-49 - 11 seconds ago
- Zometa and Myxomatous Mitral Valve for Women aged 40-49 - 11 seconds ago
- Zometa and Floppy Mitral Valve for Women aged 40-49 - 11 seconds ago
- Zometa and Billowing Mitral Valve for Women aged 40-49 - 11 seconds ago
- Zometa and Barlow'S Syndrome for Women aged 40-49 - 12 seconds ago